Tiffany Grezmak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tiffany Grezmak has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Rachel Galioto
Mellen Center for Multiple Sclerosis Neurological Institute Cleveland Clinic Cleveland Ohio USA
2 shared publications - Amy Kunchok
Department of Neurology, Mellen Center for Multiple Sclerosis Cleveland Clinic Cleveland Ohio USA
1 shared publication Carol Swetlik
From the Cleveland Clinic Mellen Center for MS (R.G., J.R.A., A.K.); Department of Neurology (T.G., C.S.), Cleveland Clinic, OH; Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam, Netherlands; Department of Neurology (C.F.), Charité - Universitätsmedizin Berlin, Germany
1 shared publication- Carsten Finke
Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany
1 shared publication Daniel Ontaneda
Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH USA
1 shared publicationJohn W. Lace
Neurological Institute, Section of Neuropsychology, Cleveland Clinic, Cleveland, OH USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 11 (1)
Neuropsychological Testing in Autoimmune Encephalitis
Background and Objectives Identifying optimal methods for evaluation and monitoring of cognitive outcomes in AE is important for clinical care and research. This scoping review aimed to evaluate neuropsychological tests (NPT) that are most frequently impaired in AE cohorts to provide recommendations for a standardized NPT battery for AE outcome. Methods PubMed search for studies examining NPT in patients with AE was conducted on June 9, 2023. Studies were screened for inclusion/exclusion criteria as follows: at least 1 NPT, individual NPT test scores with comparison with healthy controls or normative data and neural-IgG status, total sample size ≥5, and English manuscript available. Results The search yielded 5,393 studies, of which 3,359 were screened, 107 were full text reviewed, and 32 met inclusion/exclusion criteria, anti-NMDA-R (k = 18), anti-LGI1 (k = 10), anti-GABAB-R (k = 2), anti-GAD-65 (k = 4), and anti-CASPR2 (k = 3). The cognitive domains most frequently impaired were visual and verbal episodic memory, attention/working memory, processing speed, and aspects of executive functions. Discussion Given the dearth of literature examining NPT in AE in combination with small sample sizes and methodological differences, more research in this area is needed. However, we provide recommendations for a test battery to be used in future studies, with the aim of standardizing research in this area. Based on the available literature, we recommend the use of comprehensive NPT batteries, spanning all cognitive domains. The highest yield measures may include the tests of (1) visual and verbal learning/memory, (2) basic and sustained attention, (3) processing speed, and (4) executive functions.
- 1 January 2024
- Published by Wolters Kluwer Health in Neurology Neuroimmunology & Neuroinflammation
- Vol. 11 (1)
Open AccessNeuropsychological Testing in Autoimmune Encephalitis
Background and Objectives Identifying optimal methods for evaluation and monitoring of cognitive outcomes in AE is important for clinical care and research. This scoping review aimed to evaluate neuropsychological tests (NPT) that are most frequently impaired in AE cohorts to provide recommendations for a standardized NPT battery for AE outcome. Methods PubMed search for studies examining NPT in patients with AE was conducted on June 9, 2023. Studies were screened for inclusion/exclusion criteria as follows: at least 1 NPT, individual NPT test scores with comparison with healthy controls or normative data and neural-IgG status, total sample size ≥5, and English manuscript available. Results The search yielded 5,393 studies, of which 3,359 were screened, 107 were full text reviewed, and 32 met inclusion/exclusion criteria, anti-NMDA-R (k = 18), anti-LGI1 (k = 10), anti-GABAB-R (k = 2), anti-GAD-65 (k = 4), and anti-CASPR2 (k = 3). The cognitive domains most frequently impaired were visual and verbal episodic memory, attention/working memory, processing speed, and aspects of executive functions. Discussion Given the dearth of literature examining NPT in AE in combination with small sample sizes and methodological differences, more research in this area is needed. However, we provide recommendations for a test battery to be used in future studies, with the aim of standardizing research in this area. Based on the available literature, we recommend the use of comprehensive NPT batteries, spanning all cognitive domains. The highest yield measures may include the tests of (1) visual and verbal learning/memory, (2) basic and sustained attention, (3) processing speed, and (4) executive functions.
- 14 February 2023
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 71, 104579
“It's on the tip of my tongue!” exploring confrontation naming difficulties in patients with multiple sclerosis
- 14 February 2023
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 71, 104579
“It's on the tip of my tongue!” exploring confrontation naming difficulties in patients with multiple sclerosis
- Open Access
- 17 August 2022
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 37 (6) , 1355
A-200 “It’s on the Tip of My Tongue!” – Base Rates and Neuroanatomical Correlates of Confrontation Naming Deficits in Patients with Multiple Sclerosis
Objective: Word-finding difficulty is a commonly reported complaint in patients with multiple sclerosis (pwMS), though it is often under evaluated in clinical care. This study sought to identify base rates of confrontation naming impairments relative to other language tasks and examine its neuroanatomical correlates in pwMS. Method: Of 372 pwMS referred for neuropsychological assessment, 185 (MAge=48.8±11.23; MEd=14.5±2.4; 83% White; 73% women) met inclusion criteria for the final sample (i.e., estimated premorbid IQ ≥70, English-speaking, valid data on performance validity indices). Norm-based T scores for the following tests were of interest: Boston Naming Test (BNT); Controlled Oral Word Association Test (COWAT); and Animal Fluency (AF). A subset of 50 patients underwent recent quantitative MRI variables for whole brain fraction (WBF) and white matter lesion burden (T2LV). Results: PwMS showed greater impairment (≤1.5 SD) on the BNT (27.6%) as compared to AF (18.4%; p=.002), but not COWAT (24.3%; p=.304) based on binomial tests. Controlling for age and sex, significant partial correlations (ps<.05) were identified between BNT and both WBF (r=.32) and T2LV (r=-.30) and between AF and T2LV (r = -.30). COWAT did not correlate significantly with WBF (r=.08) or T2LV (r=-.09). Conclusions: Confrontation naming is relatively frequently impaired in pwMS, and correlates with both cerebral volume and lesion burden. Semantic fluency correlated only with lesion burden, and phonemic fluency did not correlate with neuroimaging. Future research should continue to investigate the clinical presentation and neuroanatomical underpinnings of language dysfunction, particularly naming/word-finding difficulties, in pwMS.
- 17 August 2022
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 37 (6) , 1355
Open AccessA-200 “It’s on the Tip of My Tongue!” – Base Rates and Neuroanatomical Correlates of Confrontation Naming Deficits in Patients with Multiple Sclerosis
Objective: Word-finding difficulty is a commonly reported complaint in patients with multiple sclerosis (pwMS), though it is often under evaluated in clinical care. This study sought to identify base rates of confrontation naming impairments relative to other language tasks and examine its neuroanatomical correlates in pwMS. Method: Of 372 pwMS referred for neuropsychological assessment, 185 (MAge=48.8±11.23; MEd=14.5±2.4; 83% White; 73% women) met inclusion criteria for the final sample (i.e., estimated premorbid IQ ≥70, English-speaking, valid data on performance validity indices). Norm-based T scores for the following tests were of interest: Boston Naming Test (BNT); Controlled Oral Word Association Test (COWAT); and Animal Fluency (AF). A subset of 50 patients underwent recent quantitative MRI variables for whole brain fraction (WBF) and white matter lesion burden (T2LV). Results: PwMS showed greater impairment (≤1.5 SD) on the BNT (27.6%) as compared to AF (18.4%; p=.002), but not COWAT (24.3%; p=.304) based on binomial tests. Controlling for age and sex, significant partial correlations (ps<.05) were identified between BNT and both WBF (r=.32) and T2LV (r=-.30) and between AF and T2LV (r = -.30). COWAT did not correlate significantly with WBF (r=.08) or T2LV (r=-.09). Conclusions: Confrontation naming is relatively frequently impaired in pwMS, and correlates with both cerebral volume and lesion burden. Semantic fluency correlated only with lesion burden, and phonemic fluency did not correlate with neuroimaging. Future research should continue to investigate the clinical presentation and neuroanatomical underpinnings of language dysfunction, particularly naming/word-finding difficulties, in pwMS.